Ovid Therapeutics CEO Jeremy BChir's 2019 pay rises 13% to $3M
Ovid Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 23, 2020
Ovid Therapeutics reported fiscal year 2019 executive compensation information on April 23, 2020.
In 2019, three executives at Ovid Therapeutics received on average a compensation package of $1.8M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Ovid Therapeutics
Jeremy Levin, DPhil, MB BChir, Chief Executive Officer, received $3M in total, which increased by 13% compared to 2018. 73% of BChir's compensation, or $2.2M, was in option awards. BChir also received $265K in non-equity incentive plan, $530K in salary, as well as $26K in other compensation.
Amit Rakhit, Chief Marketing Officer, received a compensation package of $1.6M, which increased by 3% compared to previous year. 56% of the compensation package, or $897K, was in option awards.
Timothy Daly, EVP, Finance, Corporate Controller & Treasurer, earned $897K in 2019.
Related executives
You may also like
Source: SEC filing on April 23, 2020.